Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Neurofilament Light Chains as a Biomarker in Hereditary Amyloidosis (ATTRv), Including Correlation With Various Measurements of Disease Severity and Progression.

NCT05879874 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.

NCT NCT05879874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05879874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Neurofilament Light Chains as a Biomarker in Hereditary Amyloidosis (ATTRv), Including Correlation With Various Measurements of Disease Severity and Progression.
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase
Observational
Overall status
Active, not recruiting
Start date
September 1, 2023
Completion date
June 30, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis, hereditary